Epidemiology of Non-Alcoholic Fatty Liver Disease
The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20–30%. About 2–3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. As a rule, the prevalence of NAFLD is higher in males and increases with increasing age, and it is influenced by the diagnostic method and the characteristics of the population, especially lifestyle habits. Population-based studies provide better estimates of the prevalence of NAFLD as compared to autoptic and clinical studies, but few such studies have been performed to date. The diagnosis of NAFLD in population studies is usually obtained by ultrasonography, which is known to underestimate the prevalence of fatty liver. The Dallas Heart Study and the Dionysos Study reported that 30% of the adults in the USA and 25% in Italy have NAFLD. In these studies, 79% and 55% of patients with NAFLD had normal aminotransferase levels, showing that liver enzymes are not surrogate markers of NAFLD in the general population. Noninvasive markers such as the fatty liver index obtained from the Dionysos Study may be useful to screen for NAFLD in the general population. The most important risk factors for NAFLD are male gender, age, obesity, insulin resistance and the cardiometabolic alterations that define the metabolic syndrome. The prevalence of NAFLD is 80–90% in obese adults, 30–50% in patients with diabetes and up to 90% in patients with hyperlipidemia. The prevalence of NAFLD among children is 3–10%, rising up to 40–70% among obese children. Moreover, pediatric NAFLD increased from about 3% a decade ago to 5% today, with a male-to-female ratio of 2:1. The incidence and natural history of NAFLD are still not well defined, but it is recognized that the majority of individuals with NAFLD do not develop NASH. The incidence of NAFLD is probably increasing in Western countries, strictly linked to lifestyle habits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of NAFLD among normal-weight children is 3–10%, rising up to 40–70% among obese children”
From Lack of Exercise Is a Major Cause of Chronic Diseases (2012) · cites this paper as [33]
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · cited 1×
“In the literature, many competing definitions of the MS are available. The definition recently put forth by the International Federation for the Study of Diabetes (IDF) [”
BackgroundNonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , , , , , , , , , ,”
MethodNonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · cited 1×
“] and 15p in Asian countries [ , , , , , , , , , ,”
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042 · cited 1×
“We suggest to expand the number of prospective cohort studies in the general population, even if they are more expensive and difficult to handle, because they give more reliable results about the burden of disease attributable to NAFLD. The most simple, noninvasive and practical method for diagnosing FL in population…”
BackgroundSelf-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679 · cited 1×
“Population and clinical studies have increasingly shown that most cases of NAFLD are associated with the metabolic syndrome (MS), so that NAFLD is presently considered the hepatic manifestation of MS [”
BackgroundNonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154 · cited 1×
“Definition and Classification of Non-Alcoholic Fatty Liver DiseaseNon-alcoholic fatty liver disease (NAFLD) is operationally defined as fatty liver (FL), i.e. an accumulation of lipids inside the hepatocytes exceeding 5p of the weight of the liver, without hepatitis B virus or hepatitis C virus infection and in the ab…”
BackgroundIndependent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610 · cited 1×
“A recent study showed that 27p of US adults have raised levels of liver enzymes and that 79p of these values cannot be explained by the most common causes of liver disease [ , , , , , , , ,”
BackgroundAssociation of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568 · cited 1×
“While steatosis is usually associated with a benign prognosis, steatohepatitis and fibrosis may progress to cirrhosis and possibly hepatocarcinoma.During the last decade, the number of studies on NAFLD has grown exponentially, and new concepts have been acquired by the scientific community. We now know that NAFLD is o…”
Background
Research works printed but not linked: 7
- 10.1097%2f00005176-200001000-00017 · doi:10.1097/00005176-200001000-00017 · Paper page
- 10.1016%2fs1590-8658%2802%2980194-3 · DOI
- 10.1111%2fj.1572-0241.2001.04052.x · doi:10.1111/j.1572-0241.2001.04052.x · Paper page
- 10.1016%2fs0168-8278%2801%2900094-0 · DOI · Paper page
- 10.1111%2fj.1572-0241.1999.01451.x · doi:10.1111/j.1572-0241.1999.01451.x · Paper page
- 10.3109%2f00365527709181339 · DOI · Paper page
- 10.1053%2fgast.2001.25540 · DOI · Paper page
Cited by
Items 901–1,000 of 1,000
Kowal, E., Pearson, G., Peacock, C. S., Jamieson, S. E., & Blackwell, J. M. (2013)
PLASMA HOMOCYSTEINE LEVELS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
Orlovskyi, V. F., Кучма, Н. Г., & Orlovskyi, O. V. (2014)
McCall, K. D., & Schwartz, F. (2015) · US Endocrinology · doi:10.17925/use.2015.11.1.17
Maggioni, L. (2014) · Americanae (AECID Library)
Hirashima, N. (2016) · Journal of Gastrointestinal Disorders and Liver Functions · doi:10.15436/2471-0601.15.006
Screening for NAFLD in high‐risk populations
Lessan, N. G. (2016) · Wiley eBooks · doi:10.1002/9781118924938.ch18
PNPLA3 Polymorphism and Nonalcoholic Fatty Liver Disease
Kolesnikova, O. V., Nemtsova, V. D., & Rajendram, R. (2016) · Exposure and Health · doi:10.1007/978-94-007-7742-2_28-1
Karacaer, Z., Okur, G., Çermık, H., & Özgür, A. V. C. I. (2016) · Viral Hepatitis Journal · doi:10.4274/vhd.84755
“GGT (0-55 U/L)* 24 (7-114) 29 (13-112) 23 (7-114) <0.”
BackgroundA Fatty Liver Is Neither Appetizing Nor Healthy
(2016) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000090
Diet-induced phenotypic plasticity during aging
Rusli, F. (2016) · doi:10.18174/387386
Bécares, N., Gage, M., Martin‐Gutierrez, L., Shrestha, E., Louie, R., Pourcet, B., Pello, Ó. M., Luong, T. V., Goñi, S., Liang, N., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/127779
In Vivo Role of JAK2 in the Pathogenesis of Obesity and the Metabolic Syndrome
Shi, S. Y. (2015) · TSpace (University of Toronto)
Mulder, P., van Koppen, A., van den Hoek, A. M., & Kleemann, R. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31641-0
Autophagy Regulation after Diet and Exercise in Non-alcoholic Fatty Liver Disease
Rosa, M. E. (2016) · Journal of the Arkansas Academy of Science
Prysyazhnyuk, V. P., Voloshyn, O. I., & Pashkovska, N. V. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.13.3.2017.104106
“ru Introduction In recent decades, a significant increase in the prevalence of nonalcoholic fatty liver disease (NAFLD) is observed, which occurs in about one third of adults in Western Europe and North America and in 15 % of Asian population [3].”
BackgroundThe role of CFP1 in maintaining liver homeostasis in a murine model
Chittajallu, N. (2017) · Purdue e-Pubs (Purdue University System) · doi:10.7912/c2/2193
Effects of LXRα phosphorylation on the regulation of lipid metabolism and hepatic fibrosis
Bécares, N. (2017) · UCL Discovery (University College London)
Adolescents and Bariatric Surgery: Techniques and Outcomes
Chen, J., & Ibele, A. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-71282-6_46
Cobbina, E. (2018) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-cobbina-enoch-2018
Clinical Manifestations of Liver Disease in Diabetes Mellitus
Virović-Jukić, L., Forgač, J., Ogresta, D., Filipec-Kanižaj, T., & Mrzljak, A. (2018) · Clinical gastroenterology · doi:10.1007/978-3-319-75856-5_21 · Cited by 1
Li, C., Sun, K., & Wang, H. (2018) · International Conference on Applied Science, Engineering and Technology (ICASET) · doi:10.2991/icaset-18.2018.42
Carhart, J. M. (2017) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2827
“However, authors have since demonstrated that males are twice as likely to develop NAFLD than females (441).”
BackgroundMETABOLIC SYNDROME AND METABOLISM-ASSOCIATED DISEASES OF THE DIGESTIVE SYSTEM
Игоревна, У. Н. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-19-112-119
Preoperative Preparation and Workup
Kemmeter, P. R., & Krebill, E. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-93545-4_34
The rs738409 (I148M) Variant of the PNPLA3 Gene and Type 2 Diabetes in Yakutia
Sydykova, L. A., Yakutsk, T. R. O. S. (., Куртанов, Х. А., Borisova, N., Pavlova, N., Степанов, К. М., Markova, S. V., Makarov, A., Alekseeva, S., & Antipina, U. I. (2018) · International Journal of Biomedicine · doi:10.21103/article8(3)_oa6
Dattaroy, D. (2017) · Scholar Commons (University of South Carolina)
Yarynych, Y. (2018) · Bukovinian Medical Herald · doi:10.24061/2413-0737.xxii.2.86.2018.46
“Поширеність НАЖХП також збільшується з віком (до 46%) [12].”
Abnormal Glucose Metabolism in Nonalcoholic Fatty Liver Disease
Li, M., Zhang, L., & Ji, G. (2018) · Integrative Gastroenterology and Hepatology · doi:10.18314/igh.v1i1.1210
Regier, M. C., & Stevens, K. R. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012683-00253
Effects of Vitamin E in non alcoholic fatty liver disease
Divakar, R. (2018)
The inflamed liver: RAGE and Gluttony
Bijnen (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190222mb
Tsuchiya, S. (2018) · Institutional Repositories DataBase (IRDB)
Non-alcoholic Fatty Liver in the Pathogenesis of Diabetes
Nogueira, C. A. V., & Leite, N. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_15
Eilers, S. E., Torbeck, R. L., Krishnasamy, S., & Khorasani, H. (2019) · Dermatologic Surgery · doi:10.1097/dss.0000000000002041
“The current prevalence of the population of Western countries with nonalcoholic steatotic hepatitis is at 2% to 3%and obese adults with nonalcoholic fatty liver disease at 80% to 90%.(4)Theprevalenceofpatients in theUnitedStateswith chronically active hepatitis C virus is 2.”
BackgroundEffect of Jiangzhi tablet on serum indexes of mice with fatty liver induced by CCL4
Geng, X., Kong, X., Li, C., Hao, S., Wang, H., Chen, W., & Zhang, Z. (2018) · AIP conference proceedings · doi:10.1063/1.5034283
Saravanakumar, A. (2019) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-saravanakumar-anitha-2019
Li, C., Kong, W., Kang, L., Zhang, T., Zhang, W., & Wang, W. (2020) · Journal of Medical Biochemistry · doi:10.5937/jomb0-24666
RASHAD, M. D. S. M. A. N. M., & MAHA A. FATHY, M. D. ;. S. E. S. (2020) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2020.93975
ESTUDO DA ASSOCIAÇÃO ENTRE O DESFRALDE E O USO DO EU
Moraes, A. V. P. M., Lerner, R., & Amaral, L. Q. (2020) · doi:10.22533/at.ed.1832017069 · Cited by 1
Fernando, D. H., Forbes, J. M., Angus, P., & Herath, C. B. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamb.1.2020.25
Adipocinas e consumo alimentar de mulheres obesas com doença hepática gordurosa não alcoólica
Magalhães, G. C. B. (2011)
Price, J. K., Escheik, C., Weinstein, A. A., Winter, P. M., Gerber, L. H., & Younossi, Z. M. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13938 · Cited by 1
Évolution des déterminants des maladies chroniques du foie au Québec
Sanabria, A., Dion, R., Lucar, E., & Soto, J. (2013) · Maladies chroniques et blessures au Canada · doi:10.24095/hpcdp.33.3.04f
Alam, S. M. N. E., Das, D. C., Alam, M. S., Mohsena, M., & Mahtab, M. A. (2019) · Bangladesh Medical Journal · doi:10.3329/bmj.v48i1.50191
Zayas, R., Sisson, A., Kuhnsman, A., Nagalo, B. M., Roberts, L. R., & Buetow, K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.01.404285
Sureda, A., Capó, X., & Tejada, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816488-4.00007-3
Das, D. C., Alam, S. M. N. E., Das, R., Mohsena, M., & Mahtab, M. A. (2019) · Bangladesh Medical Journal · doi:10.3329/bmj.v48i2.51258
Abating abdominal adiposity: Modifiable lifestyle risk factors for visceral and liver fat deposition
Eekelen, E. W.-V. (2020) · Leiden Repository (Leiden University)
Diakonova, A., Куртанов, Х. А., Pavlova, N. I., & Aleksandrova, T. (2021) · International Journal of Biomedicine · doi:10.21103/article11(1)_oa16
Non-Alcoholic Fatty Liver Disease
Kim, J. H. (2014) · Korean Journal of Family Practice · Cited by 1
To Identify and Examine the Different Causes of Liver Disease in Sri Lanka
Aslam, F., & Kulasena, H. (2017) · International Journal of Science and Research (IJSR) · doi:10.21275/art20178732
Silva, R. Y. D. O. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2021.tde-11062021-075429
Editorial: Machine Learning for Non/Less-Invasive Methods in Health Informatics
Qian, K., Zhang, L., Li, K., & Liu, J. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.763109
“Sang et al. introduced a model using blood markers and logistic regression for diagnosis of fibrosis in southeast Asian patients suffering from the non-alcoholic fatty liver disease (NAFLD) (14).”
MethodPersonalised medicine for Non-Alcoholic Fatty Liver Disease
Taylor, A. (2021) · Discovery Research Portal (University of Dundee)
ZHX2 REGULATION OF LIPID METABOLISM AND THE BALANCE BETWEEN CARDIOVASCULAR AND HEPATIC HEALTH
Creasy, K. T. (2015) · UKnowledge (University of Kentucky)
Effects of nuts and unsaturated fatty acids on Nonalcoholic Fatty Liver DiseasePreprint
Xu, Y., & Zhang, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1197665/v1
“NAFLD is the most common liver disease, occurring in about 90% of obese patients and 50% of diabetics[23, 24].”
BackgroundRaffele, E. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_31
The complement system and cardiovascular disease: the CODAM study
Hertle, E. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160401eh
Gu, Y., Meng, G., Chen, X., Wang, J., Zhang, Q., Liu, L., Wu, H., Zhang, S., Zhang, T., Wang, X., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1321357/v1
van de Wier, B. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160705bw
Vettor, R., & Angelo, D. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66105-6
Pi, Z., Wang, M., Lin, H., Guo, Y., Chen, S., Diao, X., Xia, H., Liu, G., Zeng, J., Zhang, X., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-111720/v2
A Recent Research on Non Alcoholic Fatty Liver Disease
(2019) · International Journal of Recent Technology and Engineering (IJRTE) · doi:10.35940/ijrte.d1151.1284s219
PNPLA3 Polymorphism and Nonalcoholic Fatty Liver Disease
Kolesnikova, O. V., Nemtsova, V. D., & Rajendram, R. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7675-3_28
Yang, Y., Tian, C., Dai, J., Zhang, W., Li, S., Xiang, M., Wang, Y., & Cao, J. (2020) · doi:10.21203/rs.3.rs-15691/v2
Non-Alcoholic Fatty Liver Disease in First Degree Relatives of Patients with Nafld
(2017) · Journal of Clinical Review & Case Reports · doi:10.33140/jcrc/02/02/00003
“The overall prevalence of NAFLD in western countries varies from 15-40% and in Asian countries from 9-40% [2, 3].”
BackgroundUpdates in the Epidemiology of Fatty Liver and its Consequences in Saudi Arabia: A Review
Alanazi, B. M. (2022) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2022/v34i46b36387
Brechko, A. Y. (2021) · Терапевтика · doi:10.31793/2709-7404.2021.2-3.70
Surveillance for Patients at Risk of Developing Hepatocellular Carcinoma
Comandini, U. V. (2022) · Updates in surgery/Updates in surgery series · doi:10.1007/978-3-031-09371-5_22
Miri, S., Komeili, G., Niazi, A., & Shahraki, M. (2021) · Armaghane Danesh · doi:10.52547/armaghanj.26.6.884
Nonalcoholic Fatty Liver in the Pathogenesis of Diabetes
Nogueira, C. A. V., & Leite, N. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_16
Zhao, C., Zhao, X., Ji, G., Li, S., & Zhou, L. (2023) · Research Square · doi:10.21203/rs.3.rs-3002358/v1
Genetics and Epigenetics in Nonalcoholic Fatty Liver Disease
Suceveanu, A., Micu, S. I., Stoian, A. P., Mazilu, L., Gherghina, V., Parepa, I. R., & Suceveanu, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-33548-8_5
Kusu, Y., Furuta, M., & Takeshita, T. (2023) · Current Oral Health Reports · doi:10.1007/s40496-023-00342-3
Li, J., Li, X., & Hao, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3297462/v1
Lipidomic Profiling in Clinical Practice Using LC-MS
Amigó, N., & Betes, P. O. (2023) · Springer eBooks · doi:10.1007/978-981-99-5162-8_11
Amigó, N., & Betes, P. O. (2023) · Springer eBooks · doi:10.1007/978-981-99-5162-8_12
PREVALENCE OF METABOLIC RISK FACTORS IN NON-ALCOHOLIC FATTY LIVER DISEASE
Ashraf, N., Sarfraz, T., Mumtaz, Z., & Rizwan, M. (2017) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v67i2.387 · Cited by 1
Combatting the Fructose Epidemic: Fruitful or Fruitless?
Buziau, A. M. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231113ab
แหวนดวงเด่น, ก. (2017) · Chulalongkorn Medical Journal · doi:10.58837/chula.cmj.61.4.7
Gallego, C. L. D. (2024) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/66294 · Cited by 1
Ramya, N., Karthikeya, G., & Shankar, S. P. (2022) · Acta Medica International · doi:10.4103/amit.amit_25_22
The Ultrasonographic Correlation of Hepatic Steatosis with Hypertension and Diabetes Mellitus
Raza, M. A., Altuf, L., Mahrukh, F., Javed, K., & Khan, S. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i1.690
Lü, H., Lei, X., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19881329
Hadei, S. K., & Abarvazn, E. (2024) · Journal of Clinical Medicine · doi:10.32592/ajcm.30.4.233
Editorial: Enriching our understanding of MASLD through representation of under‐reported populations
Samala, N. R., & Gómez, E. V. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17998
The Interplay of Iron and Lipid Homeostasis in Non-Alcoholic Fatty Liver Disease
Kidman, C. J., Mamotte, C. D. S., Inder-Smith, K. R., Tobin, M. J., Hackett, M. J., & Graham, R. M. (2024) · Journal of Renal and Hepatic Disorders · doi:10.15586/jrenhep.v8i1.170 · Cited by 1
“Dysregulation of lipid metabolism is increasingly common among the global population (21, 22), leading to increased prevalence of hepatic lipid droplets and, eventually, NAFLD (23).”
BackgroundPathipaka, S. K., Bhimarasetty, D. M., Sapuri, R. D., & Peethala, S. (2024) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20241202
Serum Malondialdehyde Levels in Patients with Non Alcoholic Fatty Liver Disease
Saikia, U. B. M. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23616141539
Nimbhorkar, P. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/mr23329161839
Shaikh, A., Pedra, G., Ruiz‐Casas, L., Franks, B., Dhillon, H. S., Fernandes, J. D. D. R., Mangla, K. K., Augusto, M., Romero‐Gómez, M., & Schattenberg, J. M. (2024) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2024.04.007
Das, D. C., Alam, S. M. N. E., Rahim, A., Razib, K. O., & Mahtab, M. A. (2024) · Bangladesh Medical Journal · doi:10.3329/bmj.v52i2.73767
Ghosh, A., & Thittai, A. K. (2024) · Ultrasonics · doi:10.1016/j.ultras.2024.107535
Association Between Cardiovascular Risk and Nonalcoholic Fatty Liver Disease
Karshina, O. O., Sabirov, I. S., Kundashev, U. K., Mohammad, E., Inarkiev, R., & Fazilova, S. (2024) · Bulletin of Science and Practice · doi:10.33619/2414-2948/109/40
Córcoles-García, S., Plaza, E. N., Gómez, C. L., Ochando, L. J., Prieto, L. F., de la Torre, C. M., & Bosch, A. F. (2024) · Revista Clínica de Medicina de Familia · doi:10.55783/rcmf.170403
Evolutionary View of Liver Pathology
Dezső, K., Paku, S., Juhász, M., Kob́ori, L., & Nagy, P. (2024) · Evolutionary Applications · doi:10.1111/eva.70059 · Cited by 1
“Nonalcoholic fatty liver disease (NAFLD) occurs in nearly 25%–50% of the population in Western countries (Bellentani, Scaglioni, and Marino 2010) and is also common in the developing world.”
Frequency of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients
Qadir, T., Ali, A., Tunio, H. K., Qadir, H., Mirbahar, I., Zakir, H., & Memon, F. (2025) · Journal of Liaquat National Hospital · doi:10.37184/jlnh.2959-1805.3.18
Metadata
- Authors
- Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G.
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 28
- Issue
- 1
- Pages
- 155-161
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2036047239
- Cited by
- 1,026
- References
- 77
- Citations by year
- 2026: 7 · 2025: 19 · 2024: 31 · 2023: 51 · 2022: 72 · 2021: 71 · 2020: 78 · 2019: 85 · 2018: 96 · 2017: 97 · 2016: 89 · 2015: 84 · 2014: 71 · 2013: 81 · 2012: 48
- FWCI
- 40.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Digestive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- non-alcoholic fatty liver disease, prevalence, nonalcoholic steatohepatitis, liver cirrhosis, hepatocellular carcinoma, risk factors, obesity, insulin resistance, metabolic syndrome, fatty liver index, NAFLD screening, pediatric NAFLD, incidence, lifestyle, transaminases
- MeSH terms
- Adult, Aged, Fatty Liver, Female, Humans, Italy, Male, Middle Aged, Risk Factors, United States, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.